LAA2 is a new clinical research study from Eli Lilly and Company. It is testing if an investigational medicine (a medicine being studied) may help treat people with obesity or overweight and type 2 diabetes.
Your participation in the study will help to determine whether an investigational vaccine helps to provide protection against RSV in different populations.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)